Carbamylation Specific Antibody Discovery Service

Background Antibody Types Discovery Strategy Types of PTM Why Choose Us? FAQs

Accelerate Your Drug Discovery Process!

Do you experience obstacles while developing antibodies? Creative Biolabs' Carbamylation-Specific Antibody Discovery Services enable you to produce high-fidelity antibodies using advanced protein engineering methods. We deliver carbamylation solutions while providing essential problem-solving capabilities.

Background

Carbamylation represents a post-translational modification process where cyanate attaches to amino or thiol groups within molecules. The process is affected by conditions such as renal disease and inflammation. Renal disease causes kidney function decline, which results in urea buildup that raises cyanate levels and consequently increases carbamylation. Inflammatory processes boost cyanate production, which results in higher carbamylation levels for proteins at inflammation sites. Multiple diseases exhibit carbamylation, including chronic kidney diseases (particularly elevated in uremic patients), cataracts (through carbamylation affecting lens crystallins, which changes protein structure and function), cardiovascular disease (where carbamylation modifies lipoproteins such as HDL and LDL to contribute to plaque formation and vascular dysfunction), and rheumatoid arthritis. RA develops anti-carbamylated protein (anti-CarP) antibodies through protein carbamylation which plays a critical role in its pathological mechanisms. Multiple chronic diseases depend on carbamylation and anti-CarP antibodies in their pathogenesis, which makes our tools vital for studying and combating these processes.

Fig. 1 Carbamylation exacerbates CKD progression and kidney function loss. (OA Literature). Fig. 1 Carbamylation, a consequence of renal function loss and an aggravating factor of CKD progression. ¹

Antibody Types

Our service enables the acquisition of monoclonal and polyclonal antibodies produced in rabbit, mouse, and sheep host animals. The antibody types include:

Site-Specific Anti-Carbamylation Antibodies: These antibodies detect carbamylation at a specific protein site. The high specificity of these antibodies allows researchers to target and analyze carbamylation effects at specific protein sites.
Pan Anti-Carbamylation Antibodies: Pan anti-carbamylation antibodies detect carbamylated lysine residues in proteins independent of their precise location. Researchers can utilize these antibodies to both detect and measure total protein carbamylation extents.

Discovery Strategy

Our antibody development services are mainly achieved through three strategies: We use three different methods to develop anti-carbamylation antibodies:

Monospecific anti-carbamylation polyclonal antibody production: The method works by producing polyclonal antibodies directed against carbamylated proteins. Polyclonal antibodies feature multiple binding sites, which provide advantages for specific applications.

Fig. 2 General process of monospecific anti-carbamylation polyclonal antibody production. (Creative Biolabs Original)

Phage display strategy for anti-carbamylation monoclonal antibody discovery: Phage display stands out as an effective approach for identifying monoclonal antibodies that exhibit both high affinity and precise specificity. Using bacteriophages to present a variety of antibody fragments makes it possible to select antibodies which target carbamylated proteins.

Fig. 3 General process of phage display for anti-carbamylation monoclonal antibody discovery. (Creative Biolabs Original)

Hybridoma strategy for anti-carbamylation monoclonal antibody discovery: The hybridoma method fuses B cells that produce antibodies with myeloma cells to make hybridomas, which are everlasting cell lines that generate monoclonal antibodies. This established traditional technique effectively produces targeted antibodies.

Fig. 4 General process of hybridoma for anti-carbamylation monoclonal antibody discovery. (Creative Biolabs Original)

Types of PTM

We provide carbamylation specific antibodies and antibodies targeting a variety of PTMs, as shown in the table below.

Why Choose Us?

Creative Biolabs' Carbamylation-Specific Antibody Discovery Service delivers numerous distinct benefits.

High Specificity and Affinity: High-Affi^TM technology from our platform enables the production of antibodies that demonstrate outstanding specificity and affinity toward carbamylated proteins.
Comprehensive Solutions: Our full range of services covers everything from antibody design through production, which we adapt to meet your unique research requirements.
Expert Team: Our experienced scientists demonstrate established excellence in antibody development, which guarantees superior quality outcomes.
Published Data: Published data supports our services by showing how reliable and effective they are.

FAQs

Q: What sample types can be used?

A: Our laboratory handles multiple sample types, such as protein samples alongside cell lysates and tissue samples. Reach out to us to discover the optimal strategy that meets your requirements. When working with formalin-fixed paraffin-embedded (FFPE) tissue samples, we can assist in optimizing your antibodies for immunohistochemistry applications.

Q: How long does the process take?

A: The timeline varies. Contact us for a detailed project timeline. The length of time required to complete the project depends on factors which include the complexity of the target antigen, along with the desired antibody affinity and the particular needs of downstream applications.

Q: What quality control is used?

A: Our antibody development process employs strict quality control standards to produce high-quality antibodies. Contact us for details. The quality control standards involve assays that verify antibody specificity, affinity, and stability alongside tests that check batch-to-batch consistency.

Q: What are the antibody applications?

A: We produce antibodies suitable for multiple applications such as ELISA, Western blotting, immunohistochemistry, and flow cytometry. Let us know your intended application. We can provide antibodies for flow cytometry that have been conjugated to appropriate fluorochromes and optimized specifically for cell staining.

Q: How do your services compare?

A: Creative Biolabs stands out from competitors through its High-Affi^TM technology alongside expertise in PTM antibodies and tailor-made solutions. Contact us to discuss your project. The High-Affi^TM technology we use produces antibodies with better affinity than traditional methods, while our mastery of post-translational modification (PTM) antibodies allows us to process complex targets.

Based on years of experience, Creative Biolabs now provides comprehensive solutions for Carbamylation-Specific Antibody Discovery. If you are interested in our services, please do not hesitate to contact us for more details.

Reference

Gorisse, Laëtitia, et al. "Carbamylated proteins in renal disease: aggravating factors or just biomarkers?." International journal of molecular sciences 23.1 (2022): 574. Distributed under Open Access license CC BY 4.0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: